F Grossi

2.2k total citations · 1 hit paper
48 papers, 998 citations indexed

About

F Grossi is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, F Grossi has authored 48 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 13 papers in Genetics and 11 papers in Hematology. Recurrent topics in F Grossi's work include Complement system in diseases (17 papers), Organ and Tissue Transplantation Research (9 papers) and Blood groups and transfusion (8 papers). F Grossi is often cited by papers focused on Complement system in diseases (17 papers), Organ and Tissue Transplantation Research (9 papers) and Blood groups and transfusion (8 papers). F Grossi collaborates with scholars based in United States, Italy and France. F Grossi's co-authors include Cedric Francois, Pascal Deschatelets, Lisa Tan, Claudio Maldonado, Joseph C. Banis, Michael Cunningham, John H. Barker, Ilene C. Weitz, Carlos de Castro and Temitayo Ajayi and has published in prestigious journals such as New England Journal of Medicine, Blood and The FASEB Journal.

In The Last Decade

F Grossi

47 papers receiving 962 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

2021 249 citations Peter Hillmen, Jeff Szer et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F Grossi United States	15	486	277	259	234	186	48	998
Kentaro Ide Japan	21	312 0.6×	151 0.5×	45 0.2×	94 0.4×	35 0.2×	138	1.5k
Kristin Page United States	18	271 0.6×	59 0.2×	645 2.5×	16 0.1×	281 1.5×	57	1.1k
Maciej Zieliński Poland	16	353 0.7×	212 0.8×	54 0.2×	28 0.1×	36 0.2×	68	872
M.B. Bradley United States	21	163 0.3×	80 0.3×	498 1.9×	9 0.0×	155 0.8×	44	1.3k
Steven C. Hoffmann United States	9	181 0.4×	102 0.4×	26 0.1×	14 0.1×	14 0.1×	11	676
Keiko Nomura Japan	20	258 0.5×	4 0.0×	195 0.8×	82 0.4×	172 0.9×	75	1.1k
Patrizia Accorsi Italy	21	172 0.4×	10 0.0×	289 1.1×	11 0.0×	145 0.8×	111	1.3k
Alice Lim United States	12	520 1.1×	9 0.0×	141 0.5×	228 1.0×	57 0.3×	14	708
Gillian Lowe United Kingdom	17	149 0.3×	7 0.0×	689 2.7×	104 0.4×	189 1.0×	44	965
Elissaveta Naumova Bulgaria	12	585 1.2×	38 0.1×	74 0.3×	15 0.1×	26 0.1×	41	874

Countries citing papers authored by F Grossi

Since Specialization

Citations

This map shows the geographic impact of F Grossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Grossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Grossi more than expected).

Fields of papers citing papers by F Grossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Grossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Grossi. The network helps show where F Grossi may publish in the future.

Co-authorship network of co-authors of F Grossi

This figure shows the co-authorship network connecting the top 25 collaborators of F Grossi. A scholar is included among the top collaborators of F Grossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Grossi. F Grossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Raymond, Yeow Tee Goh, David Gómez‐Almaguer, et al.. (2023). Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria. Blood Advances. 7(11). 2468–2478. 32 indexed citations

Latour, Régis Peffault de, Jeff Szer, Ilene C. Weitz, et al.. (2022). Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial. The Lancet Haematology. 9(9). e648–e659. 43 indexed citations

Wong, Raymond, Humphrey Pullon, Andrija Bogdanović, et al.. (2022). Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria. Annals of Hematology. 101(9). 1971–1986. 33 indexed citations

Grossi, F, Michael Yeh, Raymond Naxing Xu, & Pascal Deschatelets. (2021). The Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Pegcetacoplan Treatment in Healthy Subjects. Blood. 138(Supplement 1). 4304–4304. 2 indexed citations

Hillmen, Peter, Jeff Szer, Ilene C. Weitz, et al.. (2021). Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. New England Journal of Medicine. 384(11). 1028–1037. 249 indexed citations breakdown →

Weitz, Howard H., Peter Hillmen, Jeff Szer, et al.. (2020). RESULTS OF THE PEGASUS PHASE 3 RANDOMIZED TRIAL DEMONSTRATING SUPERIORITY OF THE C3 INHIBITOR PEGCETACOPLAN COMPARED TO ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. Hematology Transfusion and Cell Therapy. 42. 12–13. 2 indexed citations

Castro, Carlos de, Peter Hillmen, Jeff Szer, et al.. (2020). CT-286: Results of the PEGASUS Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria. Clinical Lymphoma Myeloma & Leukemia. 20. S216–S217. 1 indexed citations

Dixon, Bradley P., Larry A. Greenbaum, Liwei Huang, et al.. (2020). C3 Inhibition with Pegcetacoplan Targets the Underlying Disease Process of C3 Glomerulopathy (C3G) and Improves Proteinuria. Journal of the American Society of Nephrology. 31(10S). 577–577. 6 indexed citations

Wykoff, Charles C. & F Grossi. (2018). APL-2, a Complement C3 Inhibitor, Slows the Growth of Geographic Atrophy Secondary to AMD: 18-month Results of a Phase 2 Trial (FILLY). Investigative Ophthalmology & Visual Science. 59(9). 72–72. 1 indexed citations

10.

Kaushal, S., F Grossi, Cedric Francois, & Jason S. Slakter. (2009). Complement C3 inhibitor POT-4: Clinical Safety of Intravitreal Administration. Investigative Ophthalmology & Visual Science. 50(13). 5010–5010. 12 indexed citations

11.

Cunningham, Michael, Allen Furr, Ramsey K. Majzoub, et al.. (2006). Risk acceptance in composite-tissue allotransplantation reconstructive procedures. Microsurgery. 26(3). 144–149. 37 indexed citations

12.

Barker, John H., Allen Furr, Michael Cunningham, et al.. (2006). Investigation of Risk Acceptance in Facial Transplantation. Plastic & Reconstructive Surgery. 118(3). 663–670. 51 indexed citations

13.

Francois, Cedric, Gustavo Perez‐Abadia, F Grossi, et al.. (2006). Vascularized Lymph Node Transplantation Induces Graft-Versus-Host Disease in Chimeric Hosts. Transplantation. 81(10). 1435–1441. 11 indexed citations

14.

Majzoub, Ramsey K., Michael Cunningham, F Grossi, et al.. (2006). Investigation of Risk Acceptance in Hand Transplantation. The Journal Of Hand Surgery. 31(2). 295–302. 43 indexed citations

15.

Perez‐Abadia, Gustavo, Stephen M. Onifer, David S.K. Magnuson, et al.. (2006). Neuroregeneration in Composite Tissue Allografts: Effect of Low-Dose FK506 and Mycophenolate Mofetil Immunotherapy. Plastic & Reconstructive Surgery. 118(3). 615–623. 19 indexed citations

16.

Vasilic, Dalibor, Michael Cunningham, F Grossi, et al.. (2005). Investigation of risk acceptance in hand transplantation. Journal of the American College of Surgeons. 201(3). S50–S51. 5 indexed citations

17.

Grossi, F, et al.. (2005). Ischemic Preconditioning of Skeletal Muscle. Annals of Plastic Surgery. 55(2). 216–222. 3 indexed citations

18.

Perez‐Abadia, Gustavo, F Grossi, Cedric Francois, et al.. (2005). A novel method to reduce prolonged warm ischemia injury in amputated limbs. Journal of the American College of Surgeons. 201(3). S63–S63. 1 indexed citations

19.

Wiggins, Osborne P., John H. Barker, Serge A. Martinez, et al.. (2004). On the Ethics of Facial Transplantation Research. The American Journal of Bioethics. 4(3). 1–12. 81 indexed citations

20.

Grossi, F, et al.. (1970). [Effect of cerulein on gastrointestinal motility in humans].. PubMed. 54(4). 321–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact